For the quarter ending 2026-03-31, TDOC made $613,845K in revenue. -$64,531K in net income. Net profit margin of -10.51%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 613,845 | 642,269 | 626,439 | 631,900 |
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 197,526 | 197,048 | 187,179 | 190,537 |
| Advertising and marketing | 151,527 | 149,655 | 167,985 | 167,547 |
| Sales | 51,276 | 47,665 | 48,209 | 49,951 |
| Technology and development | 67,865 | 71,608 | 67,572 | 68,784 |
| General and administrative | 102,093 | 108,422 | 102,581 | 108,114 |
| Goodwill impairment | 0 | 0 | 12,625 | 0 |
| Acquisition, integration, and transformation costs | 1,064 | 2,233 | 1,931 | 2,658 |
| Restructuring costs | 11,975 | 6,796 | 1,950 | 5,692 |
| Amortization of intangible assets | 89,826 | 92,039 | 85,757 | 88,664 |
| Depreciation of property and equipment | 2,461 | 2,800 | 2,612 | 4,338 |
| Total costs and expenses | 675,613 | 678,266 | 678,401 | 686,285 |
| Loss from operations | -61,768 | -35,997 | -51,962 | -54,385 |
| Interest income | 6,490 | 6,951 | 7,081 | 10,064 |
| Interest expense | 5,368 | 4,950 | 4,526 | 4,473 |
| Other expense (income), net | -196 | 378 | -815 | 8,371 |
| Loss before provision for income taxes | -60,842 | -33,618 | -50,222 | -40,423 |
| Provision for income taxes | 2,995 | -8,475 | -715 | -7,763 |
| Net loss | -63,837 | -25,143 | -49,507 | -32,660 |
| Currency translation adjustment | -694 | -121 | 791 | 1,847 |
| Comprehensive loss | -64,531 | -25,264 | -48,716 | -30,813 |
| Basic EPS | -0.36 | -0.142 | -0.28 | -0.19 |
| Diluted EPS | -0.36 | -0.142 | -0.28 | -0.19 |
| Basic Average Shares | 179,122,268 | 177,879,831 | 176,934,781 | 175,917,380 |
| Diluted Average Shares | 179,122,268 | 177,879,831 | 176,934,781 | 175,917,380 |
Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC)